Fund Holdings — Aquilo Capital Management, LLC

Total Portfolio Value
$133.42M
Total Bought
$14.70M
Total Sold
$23.86M
Net Transaction
-$9.16M
Filing Period:
Securities
▲▼
SharesValue ($K)
Q4 2023
▲▼
Q1 2024
▲▼
Change
▲▼
Q4 2023
▲▼
Q1 2024
▲▼
Weight (%)
▲▼
Change
▲▼
PRECISION BIOSCIENCES INC(DTIL)0385,440+385,44005,2273.92%+5,227
SUTRO BIOPHARMA INC(STRO)420,6491,165,466+744,8171,8056,5854.94%+4,780
REGENXBIO INC(RGNX)802,424906,248+103,82414,40419,09514.31%+4,691
MERUS N V355,109255,109-100,0009,76511,4888.61%+1,722
REPARE THERAPEUTICS INC633,271633,27104,6232,9832.24%-1,640
ARROWHEAD PHARMACEUTICALS IN(ARWR)908,474908,474027,79925,98219.47%-1,817
ARVINAS INC(ARVN)489,153405,766-83,38720,13416,75012.55%-3,384
SILENCE THERAPEUTICS PLC(SLN)1,043,284574,214-469,07018,12212,4039.30%-5,719
BLUEPRINT MEDICINES CORP254,827182,151-72,67623,50517,27912.95%-6,226
KYMERA THERAPEUTICS INC(KYMR)881,337388,743-492,59422,43915,62711.71%-6,811
Page 1 of 1
Aquilo Capital Management, LLC — 13F Holdings — Q1 2024 | TickerTrail